Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy W Loo

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Journal of Thoracic Disease|January 21, 2012
Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?Billy W Loo
Current Treatment Options in Oncology|April 24, 2009
Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancerYelena Krupitskaya, Billy W Loo
JAMA Oncology|July 12, 2019
Radiotherapy and Immunotherapy-Shining Further TogetherJoshua Walker, Billy W Loo
Lancet (London, England)|April 16, 2019
SABR-COMET: harbinger of a new cancer treatment paradigmBilly W Loo, Maximilian Diehn
International Journal of Radiation Oncology, Biology, Physics|May 14, 2021
Constrained by Constraints, or Manacled by Margin Mandates?Billy W Loo, Daniel Pham
Current Treatment Options in Oncology|April 10, 2017
Optimal Radiation Therapy for Small Cell Lung CancerMichael F Gensheimer, Billy W Loo
Technology in Cancer Research & Treatment|November 13, 2010
CyberKnife stereotactic ablative radiotherapy for lung tumorsIris C Gibbs, Billy W Loo
Seminars in Radiation Oncology|June 5, 2017
Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerJennifer L Shah, Billy W Loo
Technology in Cancer Research & Treatment|March 23, 2007
RT_Image: an open-source tool for investigating PET in radiation oncologyEdward E Graves, Andrew Quon, Billy W Loo
Seminars in Radiation Oncology|March 16, 2015
To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancerDavid Benjamin Shultz, Maximilian Diehn, Billy W Loo
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Journal of Thoracic Disease|January 21, 2012
Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?Billy W Loo
Current Treatment Options in Oncology|April 24, 2009
Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancerYelena Krupitskaya, Billy W Loo
JAMA Oncology|July 12, 2019
Radiotherapy and Immunotherapy-Shining Further TogetherJoshua Walker, Billy W Loo
Lancet (London, England)|April 16, 2019
SABR-COMET: harbinger of a new cancer treatment paradigmBilly W Loo, Maximilian Diehn
International Journal of Radiation Oncology, Biology, Physics|May 14, 2021
Constrained by Constraints, or Manacled by Margin Mandates?Billy W Loo, Daniel Pham
Current Treatment Options in Oncology|April 10, 2017
Optimal Radiation Therapy for Small Cell Lung CancerMichael F Gensheimer, Billy W Loo
Technology in Cancer Research & Treatment|November 13, 2010
CyberKnife stereotactic ablative radiotherapy for lung tumorsIris C Gibbs, Billy W Loo
Seminars in Radiation Oncology|June 5, 2017
Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerJennifer L Shah, Billy W Loo
Technology in Cancer Research & Treatment|March 23, 2007
RT_Image: an open-source tool for investigating PET in radiation oncologyEdward E Graves, Andrew Quon, Billy W Loo
Seminars in Radiation Oncology|March 16, 2015
To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancerDavid Benjamin Shultz, Maximilian Diehn, Billy W Loo
Pageof 27